ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$1284.7264
|
|
AUS PBS
|
generic
|
Taltz (2) |
Eli Lilly Australia Pty Ltd |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$3909.8750
|
|
VA Big4
|
|
TALTZ (2) |
Eli Lilly & Company |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$3911.2133
|
|
VA Big4
|
|
TALTZ (3) |
Eli Lilly & Company |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$3911.8700
|
|
VA Big4
|
|
TALTZ (1) |
Eli Lilly & Company |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$3912.9200
|
|
VA Big4
|
|
TALTZ (1) |
Eli Lilly & Company |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$5241.5533
|
|
VA FSS
|
|
TALTZ (3) |
Eli Lilly & Company |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$5241.5600
|
|
VA FSS
|
|
TALTZ (1) |
Eli Lilly & Company |
TALTZ (1) |
Eli Lilly & Company |
|
ixekizumab 80 mg / 1 mL (1 mL INJECTION)
|
$5241.5650
|
|
VA FSS
|
|
TALTZ (2) |
Eli Lilly & Company |
|